Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
Clinical trial NCT05234190 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05234190
- Sponsor
- Quell Therapeutics Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2026-02-25
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.